Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation.
about
Treatment for mitochondrial disordersTreatment of mitochondrial disorders.Biomarkers of peripheral muscle fatigue during exercise.Acute liver failure after recommended doses of acetaminophen in patients with myopathiesPotential compounds for the treatment of mitochondrial disease.Diagnosis and treatment of mitochondrial myopathiesNew treatments for mitochondrial disease-no time to drop our standards.Development of pharmacological strategies for mitochondrial disorders.Drugs and mitochondrial diseases: 40 queries and answers.Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases.Tetracyclines and neuromuscular disorders.Reversible infantile mitochondrial diseases.Macrophage autophagy and oxidative stress: an ultrastructural and immunoelectron microscopical study.Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency.Comparing serum responses to acute feedings of an extensively hydrolyzed whey protein concentrate versus a native whey protein concentrate in rats: a metabolomics approach.Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.Muscle-fiber transdifferentiation in an experimental model of respiratory chain myopathy.Therapies for mitochondrial diseases and current clinical trials.Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.
P2860
Q24200432-2B7D0105-B47F-4B71-A02D-291E8BD4719FQ33794684-DADB3138-4BCC-4E4B-B30B-FA432F72A705Q34470979-70D0C1B0-DC9B-47A8-867E-4C26FA887F42Q35532037-6203B83A-F67A-4CDA-B5AF-CF3770347389Q35847813-A134FBF2-61FF-4764-84D3-E3D7A2C67507Q36634939-204F5AE6-7862-451C-B7D7-C92704878AE1Q37140299-CEDF5E8C-FB99-4578-83E5-B3A8EB90F7BAQ37686237-C72F7696-8B70-40CD-9CEF-958DD1706240Q37980195-3C15E562-1145-480C-A748-15D5B3F984F8Q38062691-914374CF-1085-4FB3-8D49-AEE49A90ACDEQ38064452-1C4DDF91-4FFA-410F-A91D-7345942CAB42Q38269312-B076EA32-D90B-4859-9144-85C1F985B0DBQ38415145-8C9F2F3D-1A84-4D41-8FF0-5E8F65517CCFQ39132635-D523F3DE-D9D3-4F6F-9F30-6C89EB2009B0Q39260993-21EB5A31-5B45-4924-BBFE-1859E4D21028Q40780781-6EC12873-B24B-4FFD-A9C8-6B3F624663E2Q43241263-BD662334-159B-4E90-968D-8670F8941604Q45872396-16B35671-0DDB-4223-A9DC-B31966F90D04Q47392210-A7849DFB-E1CD-4403-8EBE-3839060F6DE1
P2860
Oxidative stress biomarkers in mitochondrial myopathies, basally and after cysteine donor supplementation.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@en
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@nl
type
label
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@en
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@nl
prefLabel
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@en
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@nl
P2093
P50
P1433
P1476
Oxidative stress biomarkers in ...... ysteine donor supplementation.
@en
P2093
Anna Rocchi
Daniele Orsucci
Fabio Galetta
Gino Santoro
Lucia Petrozzi
Luigi Murri
Michelangelo Mancuso
P2860
P2888
P304
P356
10.1007/S00415-009-5409-7
P577
2009-12-04T00:00:00Z